Our Services
Medical Information
Helpful Resources
Published on: 2/15/2026
Dual orexin receptor antagonists (DORAs) are a newer class of prescription sleep medications that block orexin, the brain chemical that keeps you awake. For women 40 and older, DORAs can help you fall asleep and stay asleep, typically with less next-day grogginess and a lower risk of dependence than older sedatives like benzodiazepines or "Z-drugs."
Before starting a DORA, it's important to weigh side effects, potential drug and alcohol interactions, and whether you're a candidate. Ruling out underlying causes like sleep apnea, trying CBT-I and lifestyle changes, and discussing dosing and safety with your clinician are all key next steps.
Not sure if your sleep issues warrant medication—or something else entirely? Insomnia in midlife women often overlaps with hormonal shifts, anxiety, thyroid changes, or untreated sleep disorders, and identifying the real driver matters. Take a free, instant, online symptom check to better understand what's going on and confidently navigate your next steps.
Reviewed for medical accuracy: 07/03/2026
If you're a woman over 40 and struggling with sleep, you're not alone. Hormonal shifts during perimenopause and menopause, increased stress, caregiving responsibilities, and changing health conditions can all disrupt sleep. For some women, traditional sleep medications don't work well—or come with side effects that are hard to tolerate.
That's where Dual Orexin Receptor Antagonists (DORAs) come in. These newer prescription sleep medications work differently from older drugs and may offer another option for women 40+ dealing with insomnia.
Here's what you need to know.
Dual Orexin Receptor Antagonists (DORAs) are a newer class of prescription medications used to treat insomnia. They work by targeting the brain's orexin system, which helps regulate wakefulness.
Orexin (also called hypocretin) is a chemical messenger that keeps you awake and alert. When orexin activity is high, you stay awake. DORAs block orexin receptors (both OX1R and OX2R), which helps "turn down" wakefulness and allows sleep to happen more naturally.
Unlike some older sleep medications that sedate the brain broadly, DORAs specifically target the wake signal.
Currently approved DORAs include:
All are prescription medications.
Women over 40 often experience new or worsening sleep problems due to:
Sleep issues may show up as:
If you're struggling to identify the root cause of your sleep issues, this free AI-powered Sleep Disorder symptom checker can help you pinpoint potential problems and prepare informed questions for your doctor.
Many women have tried older sleep medications, such as benzodiazepines or "Z-drugs" (like zolpidem). These medications work by enhancing GABA, a calming brain chemical.
DORAs are different in key ways:
Instead of "knocking you out," DORAs reduce the brain's wake signals. This may feel more like allowing sleep rather than forcing it.
While no sleep medication is risk-free, DORAs appear to have a lower potential for dependence compared to benzodiazepines.
Research suggests DORAs may preserve more natural sleep stages compared to some older medications.
Some DORAs are particularly helpful for women who wake up during the night—not just those who have trouble falling asleep.
For women navigating midlife changes, Dual Orexin Receptor Antagonists (DORAs) may offer several advantages:
That said, individual response varies. What works well for one woman may not work for another.
No medication is completely free of side effects. DORAs are generally well tolerated, but possible side effects include:
Some people may experience:
Women over 40 should be particularly cautious if they:
It's important not to combine DORAs with alcohol or other central nervous system depressants unless specifically cleared by your doctor.
Dual Orexin Receptor Antagonists (DORAs) may not be appropriate for women who:
If you have symptoms like loud snoring, gasping at night, morning headaches, or excessive daytime sleepiness, untreated sleep apnea could be the real issue. In that case, a sleep study—not a sleeping pill—may be the safer next step.
Chronic insomnia often has multiple causes. While DORAs can help manage symptoms, they don't fix underlying triggers such as:
For long-term improvement, most experts recommend combining medication (if needed) with:
Medication can be a helpful bridge—but ideally not the only strategy.
If you're considering Dual Orexin Receptor Antagonists (DORAs), here's a simple plan:
Write down:
Patterns often reveal helpful clues.
Insomnia can sometimes signal:
Before your appointment, use this comprehensive Sleep Disorder assessment to document your symptoms and help your doctor understand the full picture of what you're experiencing.
Bring specific questions, such as:
If you experience symptoms that could be serious—such as chest pain, shortness of breath, confusion, severe daytime impairment, or signs of sleep apnea—seek medical care promptly. Always speak to a doctor about anything that could be life-threatening or serious.
It's important to stay realistic.
Dual Orexin Receptor Antagonists (DORAs) are not magic pills. They:
But for some women 40+, they can meaningfully improve sleep quality and reduce middle-of-the-night awakenings.
Better sleep can lead to:
Even small improvements in sleep can make a noticeable difference in daily life.
Sleep disruption after 40 is common—but it's not something you have to "just live with." Dual Orexin Receptor Antagonists (DORAs) represent a newer, targeted option that works by calming the brain's wake signals rather than broadly sedating you.
They may be especially helpful if:
The best approach combines smart lifestyle strategies, proper evaluation for underlying causes, and a thoughtful discussion with your healthcare provider.
If sleep has become a nightly struggle, start by understanding your symptoms, consider a structured symptom check, and speak to a doctor about whether Dual Orexin Receptor Antagonists (DORAs) might be right for you.
(References)
* Chung, S., & Im, H. (2022). Dual Orexin Receptor Antagonists as a Novel Treatment for Insomnia. *Korean Journal of Medical Sciences*, *37*(2), e119.
* Mignot, E., et al. (2022). Daridorexant, a dual orexin receptor antagonist for insomnia: a randomized, double-blind, phase 3 study. *The Lancet Neurology*, *21*(2), 125–139.
* Rosenberg, R., et al. (2021). Long-term efficacy and safety of lemborexant for the treatment of insomnia disorder: Results from the EIKON study. *Journal of Clinical Sleep Medicine*, *17*(10), 1957–1967.
* Ameratunga, D., et al. (2019). Sleep disturbances in women during the menopausal transition: The role of hormones and other factors. *Sleep Medicine Clinics*, *14*(2), 273–288.
* Yeung, J., et al. (2023). Dual Orexin Receptor Antagonists: A Review of Clinical Efficacy and Safety. *CNS Drugs*, *37*(2), 159–178.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.